Clinical trial
Evaluation Of The Diamine Oxidase Supplementation Effect In Patients With Insomnia Symptoms
NCT07027943 is registered in ClinicalTrials.gov with AB Biotek as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation Of The Diamine Oxidase Supplementation Effect In Patients With Insomnia Symptoms
- Lead sponsor
- AB Biotek
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 13, 2024
- Completion date
- December 18, 2024
- Enrollment
- 108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia, insomnia type; sleep disorder